Research Article10.1182/blood.2026033388Lichtman MA, Rowe JM. Hyperleukocytic leukemias: rheological, clinical, and therapeutic considerations. Blood. 1982;60(2):279-283.Mar 12, 2026BloodCiteListenSave
Front Matter10.1182/blood.2025032119Ready, set, GO? Treating older adults with AML.Mar 05, 2026BloodWei-Ying Jen + 1 more +1CiteListenSave
Front Matter10.1182/blood.2025032278MRD is a new therapeutic target in AML.Mar 05, 2026BloodChristian RécherCiteListenSave
Research Article10.1182/blood.2025031366Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosisMar 05, 2026BloodBárbara Mora + 37 more +37CiteListenSave
Research Article10.1182/blood.2025031521Self-reinforcing IL-1b signaling accelerates the development and recurrence of TCF3::HLF-positive B-ALL.Mar 03, 2026BloodAisa Suzuki + 18 more +18CiteListenSave
Research Article10.1182/blood.2025030630Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trial.Mar 02, 2026BloodJeff P Sharman + 17 more +17CiteListenSave
Research Article10.1182/blood.2025031202Targeting ABCD1 inhibits peroxisomal fatty acid oxidation to selectively eliminate acute myeloid leukemia cells.Feb 26, 2026BloodEkaterina N Parfenova + 6 more +6CiteListenSave
Research Article10.1182/blood.2025031663Study of NSD2 using a dTAG system reveals their molecular mechanism and oncogenic implications in t(4;14) multiple myeloma.Feb 26, 2026BloodYubao Wang + 7 more +7CiteListenSave
Front Matter10.1182/blood.2025032444CD38+ monocytes fuel fibrosis in myeloproliferative neoplasm.Feb 26, 2026BloodAlban Johansson + 1 more +1CiteListenSave
Front Matter10.1182/blood.2025032167Glutathionylated leaky mitochondrial pores as target in AML.Feb 19, 2026BloodDiego Pereira-Martins + 1 more +1CiteListenSave